MedTrace Logo

I-gel vs AuraGain for Bronchoscopic Intubation Through SGA

NCT04680169 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-06-21

No results posted yet for this study

Summary

This trial compares two different second generation supraglottic airway devices (AuraGain and I-gel) used as a conduit for bronchoscopic tracheal intubation during continuous oxygenation in order tο determine time to successful tracheal intubation and ease of use.

Conditions

  • Airway Management

Interventions

DEVICE

Bronchoscopic intubation through AuraGain LMA

Comparing two different SGAs as conduit for bronchoscopic tracheal intubation

DEVICE

Bronchoscopic intubation through I-gel SGA

Comparing two different SGAs as conduit for bronchoscopic tracheal intubation

Sponsors & Collaborators

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Charlotte V Rosenstock, Ph.d · Nordsjaellands Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-18
Primary Completion
2021-05-04
Completion
2021-05-04

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04680169 on ClinicalTrials.gov